Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer

Mass-spectrometry-based analyses have identified a variety of candidate protein biomarkers that might be crucial for epithelial ovarian cancer (EOC) development and therapy response. Comprehensive validation studies of the biological and clinical implications of proteomics are needed to advance them...

Full description

Bibliographic Details
Main Authors:	Sabine Kasimir-Bauer, Joanna Roder, Eva Obermayr, Sven Mahner, Ignace Vergote, Liselore Loverix, Elena Braicu, Jalid Sehouli, Nicole Concin, Rainer Kimmig, Lelia Net, Heinrich Roder, Robert Zeillinger, Stefanie Aust, on behalf of the OVCAD (Ovarian Cancer Diagnosis initiative)
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Cancers
Subjects:	ovarian cancer proteomics mass spectrometry survival
Online Access:	https://www.mdpi.com/2072-6694/12/9/2519

Similar Items

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium
by: Eva Obermayr, et al.
Published: (2021-11-01)

The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer—A Study of the OVCAD Consortium
by: Eva Obermayr, et al.
Published: (2021-05-01)

Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study
by: Rafał Watrowski, et al.
Published: (2022-03-01)

Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer
by: Martin Svoboda, et al.
Published: (2018-08-01)

Robust identification of molecular phenotypes using semi-supervised learning
by: Heinrich Roder, et al.
Published: (2019-05-01)

A dropout-regularized classifier development approach optimized for precision medicine test discovery from omics data
by: Joanna Roder, et al.
Published: (2019-06-01)

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium
by: Isabelle Ray-Coquard, et al.
Published: (2019-09-01)

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
by: Aust Stefanie, et al.
Published: (2012-09-01)

Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer
by: Anastasia Meshcheryakova, et al.
Published: (2019-01-01)

831 Exact Shapley values for explaining complex machine learning based molecular tests of checkpoint inhibitors: potential utility for patients, physicians, and translational research
by: Joanna Roder, et al.
Published: (2021-11-01)

tRNA<sup>GlyGCC</sup>-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression
by: Konstantina Panoutsopoulou, et al.
Published: (2021-12-01)

Combinatorial Power of cfDNA, CTCs and EVs in Oncology
by: Corinna Keup, et al.
Published: (2022-03-01)

The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
by: Corinna Keup, et al.
Published: (2023-11-01)

Multimodality in liquid biopsy: does a combination uncover insights undetectable in individual blood analytes?
by: Keup Corinna, et al.
Published: (2022-08-01)

Chondroitin Sulfate Disaccharides, a Serum Marker for Primary Serous Epithelial Ovarian Cancer
by: Karina Biskup, et al.
Published: (2021-06-01)

Sialic Acid Linkage Analysis Refines the Diagnosis of Ovarian Cancer
by: Tereza Dědová, et al.
Published: (2019-04-01)

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
by: Adriaan Vanderstichele, et al.
Published: (2022-04-01)

28 Predictions of outcomes and benefit of immune checkpoint inhibitor treatment in NSCLC require information on both tumor and host biology
by: Joanna Roder, et al.
Published: (2021-11-01)

In Situ <i>N</i>-Glycosylation Signatures of Epithelial Ovarian Cancer Tissue as Defined by MALDI Mass Spectrometry Imaging
by: Marta Grzeski, et al.
Published: (2022-02-01)

Association of Soluble B7-H4 and Circulating Tumor Cells in Blood of Advanced Epithelial Ovarian Cancer Patients
by: Pawel Mach, et al.
Published: (2021-10-01)

Explaining multivariate molecular diagnostic tests via Shapley values
by: Joanna Roder, et al.
Published: (2021-07-01)

Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
by: Horvat Reinhard, et al.
Published: (2010-12-01)

High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification
by: Siel Olbrecht, et al.
Published: (2021-07-01)

Advances in Mixer Design and Detection Methods for Kinetics Studies of Macromolecular Folding and Binding on the Microsecond Time Scale
by: Takuya Mizukami, et al.
Published: (2022-05-01)

In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor Cells
by: Sabine Kasimir-Bauer, et al.
Published: (2022-07-01)

Association of Four Interleukin-8 Polymorphisms (−251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with Ovarian Cancer Risk: Focus on Menopausal Status and Endometriosis-Related Subtypes
by: Rafał Watrowski, et al.
Published: (2024-01-01)

In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients
by: Wanja Kassuhn, et al.
Published: (2023-06-01)

Exact Shapley values for local and model-true explanations of decision tree ensembles
by: Thomas W. Campbell, et al.
Published: (2022-09-01)

Correction: Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
by: Daphne Gschwantler-Kaulich, et al.
Published: (2018-01-01)

Ovarian cancer and the immune system
by: Thaïs Baert, et al.
Published: (2017-02-01)

Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients
by: Corinna Keup, et al.
Published: (2021-01-01)

RNA Immune Signatures from Pan-Cancer Analysis Are Prognostic for High-Grade Serous Ovarian Cancer and Other Female Cancers
by: Wendell D. Jones, et al.
Published: (2020-03-01)

Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test)
by: Frank Christian Kischkel, et al.
Published: (2017-10-01)

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer
by: Sara Nasser, et al.
Published: (2022-12-01)

Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies.
by: Collaborative Group on Epidemiological Studies of Ovarian Cancer
Published: (2012-01-01)

Adoption of the 2A Ribosomal Skip Principle to Tobacco Mosaic Virus for Peptide Display
by: Juliane Röder, et al.
Published: (2017-06-01)

Circulating Tumor Cells Expressing the Prostate Specific Membrane Antigen (PSMA) Indicate Worse Outcome in Primary, Non-Metastatic Triple-Negative Breast Cancer
by: Sabine Kasimir-Bauer, et al.
Published: (2020-09-01)

Dynamics of the Intratumoral Immune Response during Progression of High-Grade Serous Ovarian Cancer
by: Mandy Stanske, et al.
Published: (2018-03-01)

Knowledge and understanding risk factors and preventive measures for osteoporosis in women: results of a survey in 502 women with and without a migration background
by: Reza Taghvaei, et al.
Published: (2022-08-01)

Sexuality as a Prognostic Factor—Results of an Individual Patient Data NOGGO (North-Eastern German Society of Gynecological Oncology)-Meta-Analysis of 644 Recurrent Ovarian Cancer Patients Prior to Chemotherapy
by: Nicole Balint, et al.
Published: (2024-02-01)